Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Lotus Pharmaceutical

Market Cap: NT$56.3b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Maxigen Biotech

Market Cap: NT$3.5b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

PharmaEngine

Market Cap: NT$12.1b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Bora Pharmaceuticals

Market Cap: NT$70.4b

Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.0b

Standard Chemical & Pharmaceutical Co. Ltd.

PharmaEssentia

Market Cap: NT$164.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.6b

Engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally.

Genetics Generation Advancement

Market Cap: NT$1.4b

Provides genetic testing and informatics services in Taiwan.

RBC Bioscience

Market Cap: NT$223.8m

Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.

TSH Biopharm

Market Cap: NT$1.8b

Develops and markets pharmaceutical products in Taiwan and Asia.

TTY Biopharm

Market Cap: NT$17.4b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

Winston Medical Supply

Market Cap: NT$1.7b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

YungShin Global Holding

Market Cap: NT$16.4b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Cenra

Market Cap: NT$6.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Adimmune

Market Cap: NT$7.5b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Yung Zip Chemical Ind

Market Cap: NT$953.4m

A bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide.

Allied Biotech

Market Cap: NT$1.6b

Manufactures and sells carotenoids worldwide.

Cenra

Market Cap: NT$4.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Nang Kuang Pharmaceutical

Market Cap: NT$3.5b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.9b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Welgene BiotechLtd

Market Cap: NT$423.0m

Provides genetic testing services.

HeXun Biosciences

Market Cap: NT$3.6b

Engages in the research and development of stem cell and treatments in Taiwan.

Synmosa Biopharma

Market Cap: NT$13.2b

A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.0b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

DV Biomed

Market Cap: NT$1.3b

Manufactures and sells medical-grade skin care products in Taiwan and China.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.6b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

BioLASCO Taiwan

Market Cap: NT$847.8m

Provides bio-materials and surgical services in Taiwan and internationally.

Handa Pharmaceuticals

Market Cap: NT$9.2b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China.